Skip to main content
Fig. 3 | Head & Face Medicine

Fig. 3

From: The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway

Fig. 3

MG132 induced inhibition of ACC-83 cells proliferation through activating Nrf2/Keap1 signaling pathway. A B Cells were treated with MG132 0µM, 10µM, 40µM and 70µM for 12 h. Western blot analysis of the protein expression of Nrf2, Keap1 and P62 between the control. All data were obtained from independent experiments. C. The protein and mRNA expression of Nrf2 was significantly increased while the protein and mRNA expression of Keap1 and P62 were decreased. All data came from three independent experiments. *P < 0.05 versus control

Back to article page

Head & Face Medicine

ISSN: 1746-160X

Contact us